Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Potassium vs Articaine Intraligamentary Injection in Pulpitis
NCT06500871Phase 1Not yet recruiting
- Sponsor
- Cairo University
- Start
- Aug 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised trial of diclofenac in irreversible pulpitis (2 arms), sponsored by Cairo University. Primary endpoint: Efficacy of local anesthesia. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
diclofenac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06500871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06500871.